TGF-²RII Knock-out iPSC-derived anti-MAGE-A4 CAR-NK cells for the treatment of mel...
Off-the-shelf engineered NK cells for the treatment of Leukemia and Lymphoma treat...
Prospection of technological trends in immunotherapy in the area of gene therapy
Development of anti-CD19-CAR specific for NK cells to enhance antitumoral effects ...
Bioengineered of T- and NK-cells by CAR against invasive fungal infections
Establishment of a platform for generating NK-CAR cells with greater therapeutic e...
Leukemic susceptibility mediated by functional ligands of natural killer cells